Prevent pregnancy, without hormones

Paragard® IUS is 100% Hormone Free

Did you know?

2/3

of women have concerns with hormones in their birth control*

Over 50%

of women used hormonal birth control anyway*

43%

of women were interested in learning about hormone-free options

When you’re counseling her

introduce

hormone and hormone-free options

Important Safety Information

  • Paragard must not be used by women who had a post-pregnancy or post-abortion uterine infection in the past 3 months; have cancer of the uterus or cervix; acute pelvic inflammatory disease (PID); an infection of the cervix; an allergy to any component (including copper); or Wilson’s disease. Continue reading

Indication

Paragard is a copper-containing IUS (intrauterine system) indicated for the prevention of pregnancy for up to 10 years.

Important Safety Information

  • Paragard must not be used by women who had a post-pregnancy or post-abortion uterine infection in the past 3 months; have cancer of the uterus or cervix; acute pelvic inflammatory disease (PID); an infection of the cervix; an allergy to any component (including copper); or Wilson's disease.
  • If a woman misses her period, she must be promptly evaluated for ectopic pregnancy.
  • Possible serious complications that have been associated with IUSs are PID, embedment, perforation of the uterus, and expulsion.
  • Paragard must not be used by pregnant women as this can be life threatening and may result in loss of pregnancy or infertility.
  • Menstrual cycles may become heavier and longer with intermenstrual spotting. Bleeding may be heavier than usual at first.
  • Paragard does not protect against HIV or STIs.

Please see accompanying Full Prescribing Information.

References:
*Based on a February 2019 web-based survey of women aged 18-45 (n=1,072) who currently use birth control, or plan to use birth control in the next 12 months. This survey was given 7 times over 1 year with no repeat respondents in the past 6 months.

†Based on a 2016 web-based survey of women in the US aged 18-34 years (N=3,020).

To be notified of placement training opportunities and product updates

Sign Up